Mydecine Speaker Series: Part II

Microdose invites you to join the Mydecine Speaker Series, dedicated to the exploration of the incredible findings around the current psychedelic research and what the path to mainstream acceptance looks like.


Mydecine Speaker Series: Part II
Jan 21, 2021, 2:00pm EST
View on YouTube

About the Event Series

Mydecine Speaker Series II – Microdosing: A Pathway to psilocybin mental health treatment

The therapeutic potential of microdosing with psychedelic medicines. This panel will discuss the benefits and challenges of Microdosing with some of the world’s top scientists.

Discover the Speakers

Elie Dolgin

Science journalist

Elie Dolgin is a freelance science journalist in Somerville, Massachusetts. He primarily covers…

Dr. Vince Polito, PhD

Science Researcher
Macquarie University

Cognitive Science Researcher at Macquarie University, Australia with significant experience in…

Robert Roscow

Chief Scientific Officer & Co-Founder
Mydecine Innovations Group Inc.

Robert Roscow, MA (Chief Scientific Officer & Co-Founder). Mr. Roscow is a highly educated…

David Erritzoe, PhD

Senior Clinical Lecturer in Psychiatry
Imperial College of London

Alongside his clinical work in medicine/psychiatry as a post-CCT psychiatrist, David conducts…

Presenting Sponsor

Mydecine Innovations Group Inc.

Mydecine Innovations Group™ (CSE:MYCO) is a publicly traded life sciences syndicate, with offices in Denver, CO, USA and Vancouver, BC, Canada.

Mydecine is dedicated to the development and production of adaptive pathway medicine and natural health products all stemming from mushrooms. Mydecine’s experienced multi-talented team has the dynamic capabilities to oversee all areas of Schedule I drug development, including but not limited to synthesis, genetic research, delivery mechanism design, clinical trial execution; through to worldwide product commercialization, marketing and spore-to-sale™ distribution of cGMP psilocybin API’s and non-psychedelic medicinal fungi.

By leveraging strategic partnerships with global scientific, medical, clinical, and Veteran organizations; Mydecine is well positioned at the forefront of naturally derived medicine, alternative therapeutics, and fungtional™ mushroom vitality consumer goods. Our portfolio of unified companies, including Mydecine Health Sciences™, Mindleap Health™, and NeuroPharm™ focus together on providing innovative and effective solutions that can help millions of people live a healthier quality life.

Frequently Asked Questions

Recordings will be put on YouTube after the show, typically within 5 business days.

For the full experience, it’s recommended that you use a personal computer running Chrome 79+ or Firefox 76+. Safari will run in lite (non-interactive) mode, meaning you can watch the panels but not interact with the features of the platform.

You’ll get an email the morning of the event with a link to access the platform.

Get Tickets Now

*If you have a coupon code, you can use it during checkout.
**Purchasing a ticket gets you lifetime access to recordings.

Privacy Preference Center